Skip to content
HowShorted

MEDICAL PROPERTIES TRUST INC short interest in 2019

In 2019, MEDICAL PROPERTIES TRUST INC's disclosed short interest ran from 4.63% of shares outstanding on 15 Jan 2019 to 3.20% on 31 Dec 2019, a change of -1.43 percentage points. The year's high was 5.31% on 28 Feb 2019 and its low 2.46% on 15 Aug 2019, averaging 3.99% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 7.07 days on 15 Jul 2019. Full history: MEDICAL PROPERTIES TRUST INC.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for MEDICAL PROPERTIES TRUST INC in 2019

2019 in figures

Start of year
4.63% (15 Jan 2019)
End of year
3.20% (31 Dec 2019)
Change
-1.43 pp
High
5.31% (28 Feb 2019)
Low
2.46% (15 Aug 2019)
Average
3.99%
Highest days to cover
7.07 (15 Jul 2019)
SEC filings marked
8

Every report in 2019

MEDICAL PROPERTIES TRUST INC short interest in 2019
SettlementShort interestDays to coverFilings since previous
15 Jan 20194.63%3.92
31 Jan 20194.78%6.64
15 Feb 20195.28%4.60results (8-K)
28 Feb 20195.31%6.62
15 Mar 20194.79%4.0910-K filed
29 Mar 20195.03%5.37
15 Apr 20195.17%6.71
30 Apr 20194.28%4.33
15 May 20194.37%6.48results (8-K), 10-Q filed
31 May 20194.60%6.19
14 Jun 20194.84%6.22
28 Jun 20194.54%4.83
15 Jul 20194.38%7.07
31 Jul 20192.91%1.17
15 Aug 20192.46%2.92results (8-K), 10-Q filed
30 Aug 20192.60%5.09
13 Sep 20192.64%2.34
30 Sep 20192.66%3.19
15 Oct 20192.52%3.97
31 Oct 20193.48%4.55results (8-K)
15 Nov 20193.07%1.4510-Q filed
29 Nov 20194.05%2.73
13 Dec 20194.06%5.08
31 Dec 20193.20%4.13

See also: MEDICAL PROPERTIES TRUST INC's full history · most shorted US stocks of 2019 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.